Adenocarcinoma of the lung medical therapy: Difference between revisions
Jump to navigation
Jump to search
Shanshan Cen (talk | contribs) No edit summary |
Shanshan Cen (talk | contribs) |
||
Line 5: | Line 5: | ||
==Medical Therapy== | ==Medical Therapy== | ||
===Stage I=== | ===Stage I=== | ||
Shown below is the algorithm on the treatment of the stage I non-small cell lung cancer based on the 2014 NCCN Non-Small Cell Lung Cancer guidelines.<ref name= | Shown below is the algorithm on the treatment of the stage I non-small cell lung cancer based on the 2014 NCCN Non-Small Cell Lung Cancer guidelines.<ref name=nccn>Non-small cell lung cancer. National Comprehensive Cancer Network 2015. http://www.nccn.org/professionals/default.aspx</ref> | ||
{{familytree/start}} | {{familytree/start}} | ||
Line 41: | Line 41: | ||
{{familytree | | | | | | | | | | | | | L01 | | L02 | | | L01=[[Non small cell carcinoma of the lung chemotherapy#Chemotherapy plus radiation therapy|chemotherapy + radiation therapy]]|L02=[[Non small cell carcinoma of the lung radiation therapy#Stereotactic Ablative Radiotherapy Usual Dosage|stereotactic ablative radiation therapy]]<br>Adjuvant [[Non small cell carcinoma of the lung chemotherapy|chemotherapy]] should be added for high-risk stages}} | {{familytree | | | | | | | | | | | | | L01 | | L02 | | | L01=[[Non small cell carcinoma of the lung chemotherapy#Chemotherapy plus radiation therapy|chemotherapy + radiation therapy]]|L02=[[Non small cell carcinoma of the lung radiation therapy#Stereotactic Ablative Radiotherapy Usual Dosage|stereotactic ablative radiation therapy]]<br>Adjuvant [[Non small cell carcinoma of the lung chemotherapy|chemotherapy]] should be added for high-risk stages}} | ||
{{familytree/end}} | {{familytree/end}} | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 18:49, 5 January 2016
Adenocarcinoma of the Lung Microchapters |
Differentiating Adenocarcinoma of the Lung from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Adenocarcinoma of the lung medical therapy On the Web |
American Roentgen Ray Society Images of Adenocarcinoma of the lung medical therapy |
Risk calculators and risk factors for Adenocarcinoma of the lung medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Overview
Medical Therapy
Stage I
Shown below is the algorithm on the treatment of the stage I non-small cell lung cancer based on the 2014 NCCN Non-Small Cell Lung Cancer guidelines.[1]
In the tumor central o peripheral? | |||||||||||||||||||||||||||||||||||||||||||
Peripheral | Central | ||||||||||||||||||||||||||||||||||||||||||
Is the tumor T1 or T2a? | |||||||||||||||||||||||||||||||||||||||||||
T1ab, N0 | T2a, N0 | T1ab-2a, N0 | |||||||||||||||||||||||||||||||||||||||||
Perform a pretreatment evaluation
| Perform a pretreatment evaluation | ||||||||||||||||||||||||||||||||||||||||||
Does the pathological evaluation showed positive disease in the mediastinal lymph nodes? | Does the pathological evaluation showed positive disease in the mediastinal lymph nodes? | ||||||||||||||||||||||||||||||||||||||||||
Yes | No | Yes | No | ||||||||||||||||||||||||||||||||||||||||
Click here for the stage III treatment | Is the tumor operable? | Click here for the stage III treatment | Is the tumor operable? | ||||||||||||||||||||||||||||||||||||||||
Yes | No | Yes | No | ||||||||||||||||||||||||||||||||||||||||
Surgical resection + lymph node dissection | stereotactic ablative radiation therapy | Surgical resection + lymph node dissection | Does the patient presents metastasis to ipsilateral peribronchial and/or hiliar nodesand intrapulmonar nodes (N1)? | ||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||
chemotherapy + radiation therapy | stereotactic ablative radiation therapy Adjuvant chemotherapy should be added for high-risk stages | ||||||||||||||||||||||||||||||||||||||||||
References
- ↑ Non-small cell lung cancer. National Comprehensive Cancer Network 2015. http://www.nccn.org/professionals/default.aspx